FDA Recall Open, Classified

NxStage PureFlow-B Solution, Premixed Dialysate for Hemodialysis, Device Catalog Numbers RFP-400, RFP-401, RFP-402, RFP-403, RFP-404, RFP-405, RFP-406, RFP-453, RFP-454, RFP-456

Recall: Z-2160-2024 · Initiated May 14, 2024

Recall

Recall Number
Z-2160-2024
Event Number
94641
Firm
NxStage Medical Inc
FEI Number
3003464075
Product Code
KPO
Status
Open, Classified
Root Cause
Under Investigation by firm
Initiated
May 14, 2024
Posted
June 20, 2024
Address
350 Merrimack St, Lawrence, MA, 01843-1748

Description

NxStage PureFlow-B Solution, Premixed Dialysate for Hemodialysis, Device Catalog Numbers RFP-400, RFP-401, RFP-402, RFP-403, RFP-404, RFP-405, RFP-406, RFP-453, RFP-454, RFP-456

Reason

The smaller chamber of the two chamber bag is bursting when nurses are attempting to mix the two chambers prior to use. The electrolyte fluid in the small chamber of the NxStage PureFlow B Solution has a pH of less than 2.0. The solution can be harmful if it comes in contact with the eyes or skin, and/or as a result of a slip or fall injury due to spilled fluid.

Action

An URGENT MEDICAL DEVICE RECALL dated 5/14/24 was sent to customers. Action to be taken by Customers 1. Check all boxes in your Pureflow B solution inventory. If you find any boxes or individual bags of Pureflow B solution from the affected lots, separate them from your other inventory and do not use them. (Refer to Appendix B for how to locate lot number). 2. Follow the instructions on the attached reply form to acknowledge your receipt of this notice. 3. Contact NxStage Customer Service ([email protected]) to arrange for the return of all affected product. We understand that dialysis fluids are critical to patient care, and immediately removing these fluids from your facility may result in the inability to treat critically ill patients. If no alternatives are available, use of PPE (goggles) and activation of bags away from patients and other personnel will limit possibility of injury due to exposure to the fluid from the small chamber. Action to be taken by NxStage NxStage is sending this notice to all facilities that have received affected RFP-4XX to alert you of the issue and request return of the Product. As a result of this action, we expect a temporary shortage of some low volume formulations for approximately 2 weeks. NxStage is working diligently to ensure expedited product availability by securing additional supply via multiple channels If you have any questions or comments, please contact NxStage Customer Service at 1-866-NXSTAGE (1-866-697-8243).

Distribution

US Nationwide distribution.

Quantity

1316936 units